Lung Cancer Proteogenomics: Shaping the Future of Clinical Investigation

Area of Science:

• Oncology
• Genomics
• Proteomics
• Proteogenomics

Background:

• Lung cancer remains a leading cause of global mortality, with genomic studies revealing some, but not all, underlying molecular mechanisms.
• Proteogenomics, the integration of genomic and proteomic profiling, offers a novel dimension for understanding lung cancer complexities.

Purpose of the Study:

• To review proteogenomic approaches applied to lung cancer research.
• To explore how understanding proteogenomic features can lead to significant clinical benefits.
• To synthesize landmark studies in lung cancer proteogenomics for personalized medicine.

Main Methods:

• Systematic review of existing literature.
• Focus on studies detailing molecular attributes, tumor biomarkers, and oncogenesis hallmarks.

Main Results:

• Proteogenomics is expected to bridge critical knowledge gaps and facilitate the discovery of new therapeutic strategies.
• Genomic profiling identifies driver mutations, while downstream analysis reveals variability in transcript-protein correlations.
• Proteogenomic characterization of major histological subtypes yields diverse predictive markers and potential drug targets.

Conclusions:

• Proteogenomics is crucial for advancing personalized medicine in lung cancer.
• This integrated approach enhances our ability to combat lung cancer through tailored treatments.